Person

Glenn S. Boehnlein

Director, Dexcom

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$25.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 2, 2024SYKSale20,000$333.00$6.7M
May 15, 2024SYKSale10,000$327.65$3.3M
Feb 9, 2024SYKSale9,600$342.81$3.3M
Feb 2, 2023SYKSale7,708$278.38$2.1M
Feb 2, 2023SYKSale125$279.96$35K
Feb 2, 2023SYKSale7,709$277.55$2.1M
Feb 2, 2023SYKSale8,883$279.52$2.5M
Dec 10, 2021SYKSale574$260.78$150K
Dec 10, 2021SYKSale447$258.98$116K
Dec 10, 2021SYKSale1,757$259.68$456K
Mar 1, 2021SYKSale2,000$246.01$492K
Dec 28, 2020SYKSale2,000$239.10$478K
Jun 15, 2020SYKSale10,351$185.24$1.9M
Oct 30, 2019SYKSale2,700$215.85$583K
Jul 30, 2019SYKSale2,700$214.16$578K
May 8, 2019SYKSale2,700$188.21$508K
Oct 1, 2018SYKSale750$178.17$134K
Apr 16, 2018SYKSale750$160.00$120K
Apr 27, 2016SYKSale2,000$109.61$219K

SEC reporting-owner ID (CIK) 1670936 · all filings on EDGAR